Abstract | PURPOSE: MATERIAL AND METHODS: Immunohistological expressions of HMGB1 and HMGB2 were assessed in 39 surgically resected human renal cancer specimens. RESULTS:
HMGB1 was expressed in the nucleus in 37 out of 39 (94.9%) renal clear cell cancers,while its expression in the cytosol was noted in 19 cases (48.7%). Cytosolic HMGB1 is expressed more frequently in cancers beyond the pT1b classification than in those at the pT1a classification. Higher tumor grades (≥ G2) were also significantly linked with the cytosolic expression of HMGB1. HMGB2 was expressed in the nucleus in 35 of 39 (89.7%) renal clear cell cancers, while its expression in the cytosol was observed in only 7 case (17.9%). Linkage between cytosolic expression of HMGB2 and T classifications was weakly observed, while that between nuclear expression and T classifications was not. CONCLUSION:
HMGB1 expressed in the cytoplasm may be an effective marker indicating higher T classifications and tumor grades.
|
Authors | Takumi Takeuchi, Koichi Sakazume, Akiko Tonooka, Masayoshi Zaitsu, Yuta Takeshima, Koji Mikami, Toshimasa Uekusa |
Journal | Urology journal
(Urol J)
Vol. 10
Issue 3
Pg. 960-5
(Sep 26 2013)
ISSN: 1735-546X [Electronic] Iran |
PMID | 24078503
(Publication Type: Journal Article)
|
Chemical References |
- HMGB1 Protein
- HMGB2 Protein
|
Topics |
- Adult
- Aged
- Aged, 80 and over
- Carcinoma, Renal Cell
(classification, metabolism, pathology)
- Cytosol
(metabolism)
- Female
- HMGB1 Protein
(biosynthesis)
- HMGB2 Protein
(biosynthesis)
- Humans
- Kidney Neoplasms
(classification, metabolism, pathology)
- Male
- Middle Aged
- Neoplasm Grading
|